Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2005
12/21/2005EP1546333A4 Aspartyl protease inhibitor as a nematode allergen
12/21/2005EP1543156A4 Detection of chemical ligation using fluorescence quenching leaving groups
12/21/2005EP1539961A4 Improved transporters and their uses
12/21/2005EP1511860A4 Improvements in and relating to a method of dna testing for------mycobacterium paratuberculosis strains
12/21/2005EP1481087A4 Zinc finger libraries
12/21/2005EP1478379A4 Humanized lactoferrin and uses thereof
12/21/2005EP1373534B1 Production of genetically modified plants with puroindolines
12/21/2005EP1335931B1 Derivatisation of proteins in aqueous solution
12/21/2005EP1307473B1 Purification of hbv antigens for use in vaccines
12/21/2005EP1265916B1 Therapeutic anti-cytomegalovirus compounds
12/21/2005EP1228097B1 Antimicrobial activity of the first cationic cluster of human lactoferrin
12/21/2005EP1222200B1 Fusion protein between HPV-L1 and a peptide, capable of forming a VLP and that functions as a vehicle for introduction of a peptide in a cell and medical uses thereof
12/21/2005EP1220934B1 Methods for making recombinant proteins using apoptosis inhibitors
12/21/2005EP1196442B1 Vgf polypeptides and methods of treating vgf-related disorders
12/21/2005EP1159426B1 Cloning and expression of haemophilus somnus transferrin-binding proteins
12/21/2005EP1155123A4 Novel adc polynucleotides and polypeptides, uses thereof including methods for improving seeds
12/21/2005EP1080182B1 Method of incorporating amino acid analogs using a hypertonic growth medium
12/21/2005EP1004238B1 Transgenic pigs
12/21/2005EP1000143B1 Frazzled nucleotide sequences, expression products, compositions and uses
12/21/2005EP0994947B1 Mu-1, member of the cytokine receptor family
12/21/2005EP0979235B1 Isolated nucleic acid molecule coding for tumor rejection antigen precursors mage-c1 and mage-c2 and uses thereof
12/21/2005EP0920524B1 A short-shafted adenoviral fiber and its use
12/21/2005EP0783573B1 Method of enhancing expression of mhc class i molecules bearing endogenous peptides
12/21/2005EP0702692B1 Regulation of antigen presentation
12/21/2005EP0698108B2 Adenoviral vectors of animal origin and use thereof in gene therapy
12/21/2005EP0680331B1 Recombinant virus immunotherapy
12/21/2005CN1711356A Method for detecting protein conformation through protein hydrolysis
12/21/2005CN1711355A Polypeptides involved in spiramycin biosynthesis, nucleotide sequences encoding said polypeptides and uses thereof
12/21/2005CN1711352A Highly permissive cell lines for hepatitis C virus replication
12/21/2005CN1711283A Kit for assaying human low-molecular weight CD14 and antibody
12/21/2005CN1711281A Use of EDG2 receptor in an animal model of heart failure
12/21/2005CN1711280A Mutation of the growth hormone in human body and its use
12/21/2005CN1711109A Positional isomers of PEG IFN alpha 2a
12/21/2005CN1711105A Compositions and methods for treating or preventing pneumococcal infection
12/21/2005CN1709910A Combined process ofr producing animal blood fiber protein
12/21/2005CN1709909A Disintegrating element for poisonous snake and its coding gene and use
12/21/2005CN1709908A Tomato RNA virus host factor and its coding gene and use thereof
12/21/2005CN1709907A Decarboxamidation grain protein-chrominium element chelate and preparation method
12/21/2005CN1232646C Plants having altered amino acid contents and method for production thereof
12/21/2005CN1232645C Method for protecting plants
12/21/2005CN1232644C Optimization method for activation of endogenetic gene of cell
12/21/2005CN1232642C Inflammatory inhibiting factor Fwa116
12/21/2005CN1232641C Modulator for function of receptor of TNF/NGF receptor family and other protein
12/21/2005CN1232533C Process for preparing uniform molecule weight polymerized hemoglobin
12/21/2005CN1232532C Fibroblast growth factor-2 analogue, producing process and application thereof
12/21/2005CN1232531C Production process and use of epidermal cell chalone
12/21/2005CN1232530C Ethene receptor protein of wheat and its coding sequence
12/20/2005US6977325 Genetic engineering of maize ubiquitin promoter to increase expression levels beyond those observed with the native type and alter tissue preference; sequence includes modification so that it does not include two overlapping heat shock elements
12/20/2005US6977296 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector
12/20/2005US6977240 Methods of using the OB receptor antibodies to treat bodyweight disorders
12/20/2005US6977176 live vector vaccine; removal of sole dependence on catalytic balanced lethal maintenance systems; plasmid partition system prevents random segregation; enhanced inheritance and stability; genetic engineering; antibiotic resistance
12/20/2005US6977175 Nucleic acids encoding lin-37 and uses thereof
12/20/2005US6977174 Circular DNA molecule with conditional origin of replication, method for preparing the same and use thereof in gene therapy
12/20/2005US6977160 Sensor protein and use thereof
12/20/2005US6977158 Mammalian IAP gene family, primers, probes, and detection methods
12/20/2005US6977157 Clock gene promoter
12/20/2005US6977154 Nucleic acid binding proteins
12/20/2005US6977150 Process and compositions for peptide, protein and peptidomimetic synthesis
12/20/2005US6977144 Nucleic acids encoding Selected Interacting Domain (SID registered) polypeptides binding selectively to a peptide encoded by a pathogenic strain of the hepatitis C virus; genetic engineering; gene therapy; bactericides;
12/20/2005US6977078 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
12/20/2005US6977074 to an antigen by sustained release to the lymphatic system; cytotoxic T lymphocytes; immunization; drug delivery
12/20/2005US6977071 Use for treatment of inflammatory diseases, HIV-infection, angiogenisis and hematopoiesis-related disorders;
12/20/2005US6977069 Contain at least two M. tuberculosis antigens; for vaccines, diagnosis, treatment
12/20/2005CA2343318C Methods of identifying and characterizing mutations within bacterial dna gyrase and fabi
12/20/2005CA2266319C Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
12/20/2005CA2188508C Gonadotropins with non-native disulfide bridges
12/20/2005CA1341491C Preparation of human igf and egf via recombinant dna technology
12/15/2005WO2005119264A1 Method for screening and compositions for treating cancers
12/15/2005WO2005119263A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 92 (gpr92)
12/15/2005WO2005119255A2 Constrained cis-diol-borate bioconjugation system
12/15/2005WO2005119251A2 Novel means and methods for the treatment of hearing loss and phantom hearing
12/15/2005WO2005118886A2 Stable peptide mimetic of hiv gp41 fusion intermediate
12/15/2005WO2005118881A2 Carrier tests for polycystic kidney disease in the cat
12/15/2005WO2005118864A2 Antibodies and related molecules that bind to psca proteins
12/15/2005WO2005118857A2 Methods and agents for screening for compounds capable of modulating vegf expression
12/15/2005WO2005118823A2 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
12/15/2005WO2005118822A2 Generation of plants with altered oil content
12/15/2005WO2005118821A2 Generation of plants with altered oil content
12/15/2005WO2005118820A2 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
12/15/2005WO2005118819A1 Generation of plants with altered oil content
12/15/2005WO2005118818A1 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
12/15/2005WO2005118817A1 Method for high speed screening for the identification of molecules inhibiting the activity of editing enzymes
12/15/2005WO2005118813A2 Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein
12/15/2005WO2005118811A1 Novel polypeptide useful for diagnosis and treatment of cancer
12/15/2005WO2005118810A1 Agents and methods for diagnosing stress
12/15/2005WO2005118809A2 Methods and compositions for enhancing cell adhesion properties
12/15/2005WO2005118790A2 Combinatorial marking of cells and cell structures with reconstituted fluorescent proteins
12/15/2005WO2005118786A2 Splice variants of peptide yy, neuropeptide y, pancreatic peptide y and amylin, and uses thereof
12/15/2005WO2005118782A2 Methods of promoting cardiac cell proliferation
12/15/2005WO2005118641A1 Splice variant of unc5h2
12/15/2005WO2005118640A2 A h+-gated ion channel
12/15/2005WO2005118639A1 Method for activating of t cell protein tyrosine phosphatase and therapeutical methods based thereon
12/15/2005WO2005118638A1 Degradation-resistant analogues of pro-insulin c-peptide
12/15/2005WO2005118637A1 Treatment of inflammatory conditions
12/15/2005WO2005118636A2 Tgf derepressors and uses related thereto
12/15/2005WO2005118635A2 Anti-cd3 antibodies and methods of use thereof
12/15/2005WO2005118634A2 Helical peptidomimetics with enhanced activity against beta-amyloid production
12/15/2005WO2005118633A2 Electrical conductors and devices from prion-like proteins
12/15/2005WO2005118632A1 A NOVEL HUMAN CARD-ONLY PROTEIN THAT INHIBITS PRO-IL-1β MATURATION
12/15/2005WO2005118631A1 Novel protein complex and use thereof
1 ... 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 ... 2916